海昇药业 — Investor Relations & Filings
About 海昇药业
Zhejiang Haisheng Pharmaceutical Co., Ltd. specializes in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates. The company's core product portfolio includes antipyretic and analgesic medications, cardiovascular agents, and various specialty chemical intermediates. It is recognized as a major global supplier of Naproxen and Naproxen Sodium. Haisheng Pharmaceutical maintains rigorous quality control systems compliant with international standards, including Good Manufacturing Practice (GMP) certifications. The company serves a diverse global clientele, providing high-purity chemical components essential for finished dosage form manufacturing. Its technical expertise focuses on chemical synthesis and process optimization to ensure stable supply chains for the pharmaceutical industry.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 董事会关于独立董事独立性自查情况专项报告 | 2026-04-15 | Chinese | |
| 2026年董事、高级管理人员薪酬方案的公告 | 2026-04-15 | Chinese | |
| 关于董事会审计委员会2025年度履职情况报告 | 2026-04-15 | Chinese | |
| 长江证券承销保荐有限公司关于浙江海昇药业股份有限公司使用部分闲置募集资金进行现金管理的专项核查意见 | 2026-04-15 | Chinese | |
| 审计报告 | 2026-04-15 | Chinese | |
| 关于使用闲置自有资金购买理财产品的进展公告 | 2026-04-02 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 40089873 | 董事会关于独立董事独立性自查情况专项报告 | 2026-04-15 | Chinese | ||
| 40089871 | 2026年董事、高级管理人员薪酬方案的公告 | 2026-04-15 | Chinese | ||
| 40089869 | 关于董事会审计委员会2025年度履职情况报告 | 2026-04-15 | Chinese | ||
| 40089868 | 长江证券承销保荐有限公司关于浙江海昇药业股份有限公司使用部分闲置募集资金进行现金管理的专项核查意见 | 2026-04-15 | Chinese | ||
| 40089866 | 审计报告 | 2026-04-15 | Chinese | ||
| 40089864 | 关于使用闲置自有资金购买理财产品的进展公告 | 2026-04-02 | Chinese | ||
| 40089858 | 关于使用部分闲置募集资金进行现金管理的进展公告 | 2026-04-02 | Chinese | ||
| 40089850 | 关于使用部分闲置募集资金进行现金管理的进展公告 | 2026-03-04 | Chinese | ||
| 40089842 | 关于使用闲置自有资金购买理财产品的进展公告 | 2026-03-04 | Chinese | ||
| 40089835 | 2025年年度业绩快报公告 | 2026-02-09 | Chinese | ||
| 40089833 | 股东拟减持股份的预披露公告（再次披露） | 2026-02-09 | Chinese | ||
| 40089828 | 关于公司再次取得高新技术企业证书的公告 | 2026-02-09 | Chinese | ||
| 40089820 | 关于使用部分闲置募集资金购买理财产品的进展公告 | 2026-02-03 | Chinese | ||
| 40089813 | 关于使用闲置自有资金购买理财产品的进展公告 | 2026-02-03 | Chinese | ||
| 40089804 | 股东拟减持股份的预披露公告 | 2026-01-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
海昇药业 via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58885/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58885 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58885 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58885 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58885}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 海昇药业 (id: 58885)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.